These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 30409296)

  • 1. Oncological and functional outcomes of trans-oral robotic surgery for pyriform sinus carcinoma: A French GETTEC group study.
    Mazerolle P; Philouze P; Garrel R; Aubry K; Morinière S; El Bedoui S; Ton Van J; Ferron C; Malard O; Jegoux F; Berard E; Vergez S
    Oral Oncol; 2018 Nov; 86():165-170. PubMed ID: 30409296
    [TBL] [Abstract][Full Text] [Related]  

  • 2. "End to Side Technique": More organ preservation with less morbidity in patients with pyriform sinus apex SCC.
    Ahmadi A; Sanaei A; Jan D
    Am J Otolaryngol; 2020; 41(4):102505. PubMed ID: 32354480
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pyriform sinus squamous cell carcinoma: oncological outcomes in good responders of induction chemotherapy-based larynx preservation protocols.
    Vourexakis Z; Le Ridant AM; Dulguerov P; Janot F
    Eur Arch Otorhinolaryngol; 2015 Jul; 272(7):1725-31. PubMed ID: 24854231
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predicting Factors for Oncological and Functional Outcome in Hypopharyngeal Cancer.
    Visini M; Giger R; Shelan M; Elicin O; Anschuetz L
    Laryngoscope; 2021 May; 131(5):E1543-E1549. PubMed ID: 33098325
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Long-term outcome of patients with pyriform sinus squamous cell carcinoma treated with planned preoperative (chemo-) radiotherapy plus laryngeal function sparing surgery].
    Huang H; Zhang ZM; Zhang Y; Wang XL; Liu SY; Xu ZG
    Zhonghua Zhong Liu Za Zhi; 2019 Jul; 41(7):535-539. PubMed ID: 31357842
    [No Abstract]   [Full Text] [Related]  

  • 6. Patterns of cervical node positivity, regional failure rates, and fistula rates for HPV+ oropharyngeal squamous cell carcinoma treated with transoral robotic surgery (TORS).
    Cannon RB; Houlton JJ; Patel S; Raju S; Noble A; Futran ND; Parvathaneni U; Méndez E
    Oral Oncol; 2018 Nov; 86():296-300. PubMed ID: 30409315
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Feasiblity of transoral robotic hypopharyngectomy for early-stage hypopharyngeal carcinoma.
    Park YM; Kim WS; Byeon HK; De Virgilio A; Jung JS; Kim SH
    Oral Oncol; 2010 Aug; 46(8):597-602. PubMed ID: 20619721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transoral robotic surgery for early T classification hypopharyngeal cancer.
    Wang CC; Liu SA; Wu SH; Wang CP; Liang KL; Jiang RS; Lin JC
    Head Neck; 2016 Jun; 38(6):857-62. PubMed ID: 26559383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neoadjuvant treatment combined with planned surgery in laryngeal function preservation for locally advanced pyriform sinus carcinoma.
    Yu Y; Wang X; Xu Z; Fan C; Tu G
    J Craniofac Surg; 2014 Nov; 25(6):1975-9. PubMed ID: 25377955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transoral robotic surgery (TORS) for laryngeal and hypopharyngeal cancers.
    Dziegielewski PT; Kang SY; Ozer E
    J Surg Oncol; 2015 Dec; 112(7):702-6. PubMed ID: 26266762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical outcomes of weekly cisplatin chemoradiotherapy for patients with pyriform sinus cancer.
    Sakashita T; Homma A; Hatakeyama H; Furusawa J; Kano S; Mizumachi T; Iizuka S; Onimaru R; Tsuchiya K; Yasuda K; Shirato H; Fukuda S
    Int J Clin Oncol; 2015 Dec; 20(6):1081-5. PubMed ID: 25804347
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Feasibility and safety of transoral robotic surgery (TORS) for early hypopharyngeal cancer: a subset analysis of the Hamburg University TORS-trial.
    Lörincz BB; Busch CJ; Möckelmann N; Knecht R
    Eur Arch Otorhinolaryngol; 2015 Oct; 272(10):2993-8. PubMed ID: 25217079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pattern of cervical lymph node metastasis in medial wall pyriform sinus carcinoma.
    Chung EJ; Lee SH; Baek SH; Park IS; Cho SJ; Rho YS
    Laryngoscope; 2014 Apr; 124(4):882-7. PubMed ID: 23832757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transoral robotic surgery in patients with stage III/IV hypopharyngeal squamous cell carcinoma: treatment outcome and prognostic factor.
    Park YM; Kim DH; Kang MS; Lim JY; Koh YW; Kim SH
    Acta Otolaryngol; 2019 Sep; 139(9):816-822. PubMed ID: 31268399
    [No Abstract]   [Full Text] [Related]  

  • 15. Transoral robotic surgery (TORS) in laryngeal and hypopharyngeal cancer.
    Park YM; Lee WJ; Lee JG; Lee WS; Choi EC; Chung SM; Kim SH
    J Laparoendosc Adv Surg Tech A; 2009 Jun; 19(3):361-8. PubMed ID: 19405798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Utilization of Transoral Robotic Surgery (TORS) in patients with Oropharyngeal Squamous Cell Carcinoma and its impact on survival and use of chemotherapy.
    Baliga S; Kabarriti R; Jiang J; Mehta V; Guha C; Kalnicki S; Smith RV; Garg MK
    Oral Oncol; 2018 Nov; 86():75-80. PubMed ID: 30409323
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Larynx preservation protocols: long-term functional outcomes in good responders to induction chemotherapy for pyriform sinus carcinoma.
    Vourexakis Z; Janot F; Dulguerov P; Le Ridant AM
    ORL J Otorhinolaryngol Relat Spec; 2014; 76(3):165-70. PubMed ID: 25074814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surgical, Oncological, and Functional Outcomes of Transoral Robotic Supraglottic Laryngectomy.
    Hans S; Chekkoury-Idrissi Y; Circiu MP; Distinguin L; Crevier-Buchman L; Lechien JR
    Laryngoscope; 2021 May; 131(5):1060-1065. PubMed ID: 32812245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical outcomes with transoral robotic surgery for supraglottic squamous cell carcinoma: Experience of a French evaluation cooperative subgroup of GETTEC.
    Razafindranaly V; Lallemant B; Aubry K; Moriniere S; Vergez S; Mones ED; Malard O; Ceruse P
    Head Neck; 2016 Apr; 38 Suppl 1():E1097-101. PubMed ID: 26435046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current management strategy of hypopharyngeal carcinoma.
    Chan JY; Wei WI
    Auris Nasus Larynx; 2013 Feb; 40(1):2-6. PubMed ID: 22709574
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.